The role of the sodium citrate transporter (NaCT) SLC13A5 is multifaceted and context-dependent. While aberrant dysfunction leads to neonatal epilepsy. its therapeutic inhibition protects against metabolic disease. Notably. https://www.ldartstudio.com/product-category/lip-colour-2/